TABLE 3.
Patient survival in the combined 395-profile data set
Patients | n | No. dead from cancer (%) | Mean survival time (yr) |
---|---|---|---|
All | 395 | 84 (21) | 10.6 |
HER2 positive | 44 | 16 (36) | 8.2 |
HER2 negative | 351 | 68 (19) | 10.8 |
Grade 3 | 112 | 33 (29) | 9.4 |
Not grade 3 | 283 | 51 (18) | 11.0 |